Screening for esophageal squamous cell carcinoma: recent advances

Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer worldwide, with a high mortality due to advanced stage at diagnosis. Although most common in an area known as the Asian Esophageal Cancer Belt, which extends from the Caspian Sea to northern China, and in parts of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gastrointestinal endoscopy Ročník 88; číslo 3; s. 413 - 426
Hlavní autoři: Codipilly, Don C., Qin, Yi, Dawsey, Sanford M., Kisiel, John, Topazian, Mark, Ahlquist, David, Iyer, Prasad G.
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Elsevier Inc 01.09.2018
Témata:
Early Detection of Cancer - methods
Esophageal Neoplasms - diagnosis
Esophageal Squamous Cell Carcinoma - diagnosis
Esophagoscopy - methods
Humans
Population Surveillance
WLE
BE
HRME
NBI
FICE
SOS
MDM
TNE
ESCC
ISSN:0016-5107, 1097-6779, 1097-6779
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer worldwide, with a high mortality due to advanced stage at diagnosis. Although most common in an area known as the Asian Esophageal Cancer Belt, which extends from the Caspian Sea to northern China, and in parts of Africa, high-risk populations also exist elsewhere in the world. Screening for ESCC has been practiced in a few geographic areas and high-risk populations, with varying levels of success. Esophageal squamous dysplasia is recognized as the precursor lesion for ESCC. Endoscopic screening for ESCC/esophageal squamous dysplasia is expensive and not sufficiently available in many high-risk regions. Recent advances in non-endoscopic screening enhanced by biomarker-based disease detection have raised the prospect of improved accuracy and availability of screening for esophageal squamous dysplasia and early stage ESCC. Development of a cost-effective, accurate, and well-tolerated screening test, if applied in endemic areas and high-risk populations, has the potential to reduce mortality from this deadly disease worldwide. In this review, we summarize recent developments in endoscopic and non-endoscopic screening modalities.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Co-first authors
ISSN:0016-5107
1097-6779
1097-6779
DOI:10.1016/j.gie.2018.04.2352